NCT02574403
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- CHU Amiens Amiens, France
- CHU Bordeaux Bordeaux, France
- CHU Caen Caen, France
- CH métropole Savoie Chambéry, France
Clinical trial condition
Atypical Hemolytic Uremic Syndrome
Explore clinical trials studying Atypical Hemolytic Uremic Syndrome. Study availability and eligibility vary by location and protocol.
17 public trials
7 recruiting studies
Atypical Hemolytic Uremic Syndrome trial results
Completed
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS
NCT00844545
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Atlanta, Georgia, United States
- Fort Wayne, Indiana, United States
- New York, United States
- New York, United States
Completed
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS
NCT00844428
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Toronto, Canada
- Bois-Guillaume, France
- Bordeaux, France
- Lyon, France
NCT00838513
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Toronto, Canada
- Bois-Guillaume, France
- Bordeaux, France
- Lyon, France
Completed
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS
NCT00844844
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Atlanta, Georgia, United States
- Fort Wayne, Indiana, United States
- New York, United States
- New York, United States
Active, Not Recruiting
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
NCT04861259
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Univ of CA San Francisco San Francisco, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Emory Children's Center Atlanta, Georgia, United States
- Washington University St Louis, Missouri, United States
Active, Not Recruiting
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
NCT04958265
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Children's Hospital Colorado Aurora, Colorado, United States
- University of Nebraska Omaha, Nebraska, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- UZ Gent Ghent, Belgium